Description
Recombinant monoclonal antibody to CCR7. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma mAb 22. This is a reformatted human IgG1 Fc SilentЩ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.
Target
CCR7
Target Alias Names
CD197, BLR2, CDw197, C-C CKR-7, CC-CKR-7, CCR-7, EBI1, C-C chemokine receptor type 7, Epstein-Barr virus-induced G-protein coupled receptor 1, EBV-induced G-protein coupled receptor 1, MIP-3 beta receptor
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression